The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC
Clinical trial NCT04830267 · UNKNOWN
Trial details
- NCT number
- NCT04830267
- Sponsor
- Chongqing University Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2024-08-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.